Copyright Reports & Markets. All rights reserved.

Global Levothyroxine Sodium API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Levothyroxine Sodium API Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 >99.5%
    • 1.3.3 >98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Levothyroxine Sodium API Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Oral
    • 1.4.3 Injection
  • 1.5 Global Levothyroxine Sodium API Market Size & Forecast
    • 1.5.1 Global Levothyroxine Sodium API Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Levothyroxine Sodium API Sales Quantity (2019-2030)
    • 1.5.3 Global Levothyroxine Sodium API Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Azico Biophore India
    • 2.1.1 Azico Biophore India Details
    • 2.1.2 Azico Biophore India Major Business
    • 2.1.3 Azico Biophore India Levothyroxine Sodium API Product and Services
    • 2.1.4 Azico Biophore India Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Azico Biophore India Recent Developments/Updates
  • 2.2 Excella
    • 2.2.1 Excella Details
    • 2.2.2 Excella Major Business
    • 2.2.3 Excella Levothyroxine Sodium API Product and Services
    • 2.2.4 Excella Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Excella Recent Developments/Updates
  • 2.3 Macleods
    • 2.3.1 Macleods Details
    • 2.3.2 Macleods Major Business
    • 2.3.3 Macleods Levothyroxine Sodium API Product and Services
    • 2.3.4 Macleods Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Macleods Recent Developments/Updates
  • 2.4 China Associate Pharma
    • 2.4.1 China Associate Pharma Details
    • 2.4.2 China Associate Pharma Major Business
    • 2.4.3 China Associate Pharma Levothyroxine Sodium API Product and Services
    • 2.4.4 China Associate Pharma Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 China Associate Pharma Recent Developments/Updates
  • 2.5 Yangzijiang Pharma
    • 2.5.1 Yangzijiang Pharma Details
    • 2.5.2 Yangzijiang Pharma Major Business
    • 2.5.3 Yangzijiang Pharma Levothyroxine Sodium API Product and Services
    • 2.5.4 Yangzijiang Pharma Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Yangzijiang Pharma Recent Developments/Updates
  • 2.6 Sandoz
    • 2.6.1 Sandoz Details
    • 2.6.2 Sandoz Major Business
    • 2.6.3 Sandoz Levothyroxine Sodium API Product and Services
    • 2.6.4 Sandoz Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sandoz Recent Developments/Updates
  • 2.7 Mylan
    • 2.7.1 Mylan Details
    • 2.7.2 Mylan Major Business
    • 2.7.3 Mylan Levothyroxine Sodium API Product and Services
    • 2.7.4 Mylan Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Mylan Recent Developments/Updates
  • 2.8 Zhangjiagang Huachang Pharmaceutical
    • 2.8.1 Zhangjiagang Huachang Pharmaceutical Details
    • 2.8.2 Zhangjiagang Huachang Pharmaceutical Major Business
    • 2.8.3 Zhangjiagang Huachang Pharmaceutical Levothyroxine Sodium API Product and Services
    • 2.8.4 Zhangjiagang Huachang Pharmaceutical Levothyroxine Sodium API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Zhangjiagang Huachang Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Levothyroxine Sodium API by Manufacturer

  • 3.1 Global Levothyroxine Sodium API Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Levothyroxine Sodium API Revenue by Manufacturer (2019-2024)
  • 3.3 Global Levothyroxine Sodium API Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Levothyroxine Sodium API by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Levothyroxine Sodium API Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Levothyroxine Sodium API Manufacturer Market Share in 2023
  • 3.5 Levothyroxine Sodium API Market: Overall Company Footprint Analysis
    • 3.5.1 Levothyroxine Sodium API Market: Region Footprint
    • 3.5.2 Levothyroxine Sodium API Market: Company Product Type Footprint
    • 3.5.3 Levothyroxine Sodium API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Levothyroxine Sodium API Market Size by Region
    • 4.1.1 Global Levothyroxine Sodium API Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Levothyroxine Sodium API Consumption Value by Region (2019-2030)
    • 4.1.3 Global Levothyroxine Sodium API Average Price by Region (2019-2030)
  • 4.2 North America Levothyroxine Sodium API Consumption Value (2019-2030)
  • 4.3 Europe Levothyroxine Sodium API Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Levothyroxine Sodium API Consumption Value (2019-2030)
  • 4.5 South America Levothyroxine Sodium API Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Levothyroxine Sodium API Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 5.2 Global Levothyroxine Sodium API Consumption Value by Type (2019-2030)
  • 5.3 Global Levothyroxine Sodium API Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 6.2 Global Levothyroxine Sodium API Consumption Value by Application (2019-2030)
  • 6.3 Global Levothyroxine Sodium API Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 7.2 North America Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 7.3 North America Levothyroxine Sodium API Market Size by Country
    • 7.3.1 North America Levothyroxine Sodium API Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Levothyroxine Sodium API Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 8.2 Europe Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 8.3 Europe Levothyroxine Sodium API Market Size by Country
    • 8.3.1 Europe Levothyroxine Sodium API Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Levothyroxine Sodium API Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Levothyroxine Sodium API Market Size by Region
    • 9.3.1 Asia-Pacific Levothyroxine Sodium API Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Levothyroxine Sodium API Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 10.2 South America Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 10.3 South America Levothyroxine Sodium API Market Size by Country
    • 10.3.1 South America Levothyroxine Sodium API Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Levothyroxine Sodium API Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Levothyroxine Sodium API Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Levothyroxine Sodium API Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Levothyroxine Sodium API Market Size by Country
    • 11.3.1 Middle East & Africa Levothyroxine Sodium API Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Levothyroxine Sodium API Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Levothyroxine Sodium API Market Drivers
  • 12.2 Levothyroxine Sodium API Market Restraints
  • 12.3 Levothyroxine Sodium API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Levothyroxine Sodium API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Levothyroxine Sodium API
  • 13.3 Levothyroxine Sodium API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Levothyroxine Sodium API Typical Distributors
  • 14.3 Levothyroxine Sodium API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Levothyroxine Sodium API is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland.
    According to our (Global Info Research) latest study, the global Levothyroxine Sodium API market size was valued at US$ 30.4 million in 2023 and is forecast to a readjusted size of USD 47.1 million by 2030 with a CAGR of 6.6% during review period.
    The Global key players of Levothyroxine Sodium API include Azico Biophore India, Excella, Macleods, etc. The top three players hold a share over 29%. China is the largest market, with a share about 30%. In terms of product type, >99.5% is the largest segment, which occupied for a share of about 82%. For application, Oral is the largest segment, which has a share about 98%.
    This report is a detailed and comprehensive analysis for global Levothyroxine Sodium API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Levothyroxine Sodium API market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Levothyroxine Sodium API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Levothyroxine Sodium API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2019-2030
    Global Levothyroxine Sodium API market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Levothyroxine Sodium API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Levothyroxine Sodium API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azico Biophore India, Excella, Macleods, China Associate Pharma, Yangzijiang Pharma, Sandoz, Mylan, Zhangjiagang Huachang Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Levothyroxine Sodium API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    >99.5%
    >98%
    Market segment by Application
    Oral
    Injection
    Major players covered
    Azico Biophore India
    Excella
    Macleods
    China Associate Pharma
    Yangzijiang Pharma
    Sandoz
    Mylan
    Zhangjiagang Huachang Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Levothyroxine Sodium API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Levothyroxine Sodium API, with price, sales quantity, revenue, and global market share of Levothyroxine Sodium API from 2019 to 2024.
    Chapter 3, the Levothyroxine Sodium API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Levothyroxine Sodium API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Levothyroxine Sodium API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Levothyroxine Sodium API.
    Chapter 14 and 15, to describe Levothyroxine Sodium API sales channel, distributors, customers, research findings and conclusion.

    Buy now